The State Board of Pharmacy (TSBP) adopted and proposed several new rules at the February quarterly meeting. 

Also in Texas, the TSBP publishes a monthly newsletter aimed at informing interested parties about law and rule changes and news relating to the practice of pharmacy in the state. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Prescription Monitoring Program (PMP) Advisory Committee Zoom meeting is scheduled for March 28. Additional information will be posted on the website as it becomes available. 

Also in Texas, the Health and Humans Services Commission (HHSC) provided information on two diabetes programs:  

• Healthy Eating Active Living (HEAL) is a program at The University of Texas in Houston that educates pregnant women and women with children about living a healthier lifestyle for them and their children. Moms participate in weekly cooking classes, exercise classes, support groups and a bag filled with fresh fruits and vegetables along with healthy recipes.  
• Texas Research-to-Policy Collaboration (TX RPC) project by the Michael and Susan Dell Center for Healthy Living aims to improve the health of Texans by “using Texas research, data and resources to assist legislators in developing effective health policies”. TX RCP supports Texas legislators by providing state-level data and research on current health issues, and by establishing partnerships between researchers and state policymakers. 

 Finally in Texas, the Statewide Health Coordinating Council, appointed by Gov. Greg Abbott (R) and administratively linked to the Department of State Health Services (DSHS), will hold its next meeting on February 29 and posted its agenda.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Gov. Greg Abbott (R) announced a May 4 special election to serve the remainder of former Sen. John Whitmire’s (D) term.  

Also in Texas, the Pharmaceutical Initiative (TPI) Board held a meeting on February 9. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The quarterly public meeting of the Board of Pharmacy will be held on February 6, at the Barbara Jordan State Office Building, Room 2.013. The agenda and meeting materials are posted. Live live-stream information is available on the board’s website. Anyone wishing to address the Board regarding an agenda item during the public meeting must submit a Public Comment Request form by 5:00 pm on February 2. Oral comments will be limited to the agenda items.  

Also in Texas, Jill Dutton (R) won the January 30 special runoff election, by 107 votes out of more than 13,500 cast, to replace expelled Rep. Bryan Slaton (R) for House District 2. The victory is short-lived as she will face off against the same GOP candidate Brent Money in the March 5 Republican primary election.  

Also in Texas, the Health and Human Services Commission (HHSC) drafted a policy to apply a uniform 90-day supply of maintenance medications in Medicaid and the Children’s Health Insurance Program (CHIP). The HHSC received pushback from stakeholders expressing difficulty obtaining a 90-day supply of medication. You can submit comments by February 15 to the HHSC Vendor Drug Program (VDP) using the Draft Policy Comment Submission form. 

Also in Texas, pharmacists and pharmacy technicians are required to notify the Board of a change of employment within ten days. This information can be found in Board rule §291.3 for pharmacists and Board rule §297.9 for pharmacy technicians.

Finally in Texas, HHSC’s VDP (Vendor Drug Program) posted a pharmacy education and opportunities page on its website so that pharmacies know what pharmacy items Medicaid pays for, which products require prior authorization and who to contact with questions about claim processing. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Medicaid Vendor Drug Program (VDP) held a virtual quarterly pharmacy stakeholder meeting on January 17. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The next quarterly meeting of the Board of Pharmacy is Tuesday, February 6, at the new Barbara Jordan State office building. The agenda will be posted here when it becomes available. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Gov. Greg Abbott (R) appointed Mike McKinney, M.D., Golinda Erowele, PharmD, and Tony Schell to the Texas Pharmaceutical Initiative Governing Board. McKinney will serve as the Chair of the Board tasked with developing a business plan to provide cost effective drugs and other medical supplies for the public employee sector. 

Also in Texas, the Governor reappointed two chain pharmacists, Rick Fernandez with Walgreens, and Julie Spier with Albertsons Companies to additional 6-year terms to the State Board of Pharmacy. Gov. Abbott also appointed two new members to the Board, Randy Martin, a pharmacist and clinical services manager at Texas Health Harris Methodist Hospital Fort Worth, and public member Garrett Marquis, chief communications officer for the Bank of New York Mellon. 

Also in Texas, the Health and Human Services Commission (HHSC) alerted providers that beginning January 1, 2024, the managed care organization Amerigroup, began operating under a new name Wellpoint.  

Finally in Texas, the State Board of Pharmacy updated licensing and renewal fees effective January 1, 2024. Fees for pharmacists and pharmacies have increased, but there was no change to pharmacy technician fees. The Board of Pharmacy also established new fees for remote pharmacies. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Health and Human Services Commission (HHSC) Vendor Drug Program (VDP) now covers the 2023-2024 Pfizer-BioNTech, Moderna and Novavax commercial COVID-19 vaccines as a pharmacy benefit for both Medicaid managed care and fee-for-service, as well as the Children’s Health Insurance Program (CHIP). 

Also in Texas, Medicaid will perform the semi-annual update of the Medicaid preferred drug list on January 25, 2024. The Health and Human Services Commission (HHSC) made the PDL changes based on recommendations made at the October 2023 Drug Utilization Review Board meeting. Drug list recommendations from the meeting are available. Drugs with preferred status drugs may include brand name medication which would not require a PDL prior authorization nor the value of “1” in the “Dispense as Written (DAW) Product Selection code” field (408-D8). Refer to the Dispense as Written section of the Formulary Coverage chapter of the Pharmacy Provider Procedure Manual for more information. 

Also in Texas, the Health and Human Services Commission (HHSC) is soliciting comments on the prospective clinical prior authorization proposals likely to be presented at the Texas Drug Utilization Review (DUR) Board meeting on January 26, 2024. The board reviews and recommends clinical criteria and the preferred or non-preferred drug status on the Medicaid formulary.  

Also in Texas, December 11 was the filing deadline for the March 5, 2024, primary election.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

United Supermarkets’ pharmacist Tim Purser and his wife Charity who is standing next to Gov. Gregg Abbott (R), accompanied NACDS to a Lubbock fundraiser for the Chair of the House Calendars Committee, Dustin Burrows (R).

Also in Texas, Texas Comptroller Glenn Hegar (R) announced the Opioid Abatement Fund Council (OAFC) decisions to approve up to $25 million over the next year of opioid settlement trust funds to be allocated for each grant plan strategy – the distribute Naloxone, the promotion of substance abuse and prevention by raising awareness of students in grades kindergarten through 12^th , as well as their parents and caregivers, and bolstering training, recruitment and retention, and certification assistance for the behavioral health workforce. The OAFC had previously approved rules for distribution of $166.7 million of the funds to more than 150 hospital districts over 18 years. Additionally, last March $47.1 million of the Opioid Abatement funds was distributed to political subdivisions.

Also in Texas, the Board of Pharmacy adopted and proposed several new rules at their November meeting.

Also in Texas, the PMP Advisory Committee meeting will be meeting virtually December 14^th.

Finally in Texas, Attorney General Ken Paxton (R) is suing Pfizer for “misrepresenting COVID-19 vaccine efficacy and conspiring to censor public discourse, arguing that Pfizer’s claim that the COVID-19 vaccine was 95% effective against infection was “highly misleading.” The lawsuit also charges that Pfizer engaged in a conspiracy to silence dissent by coordinating with social media companies to remove “truth-tellers” from their platforms.

For more information, contact NACDS’ Mary Staples at 817-442-1155.